Analysis of a dataset from The Cancer Genome Atlas using GEPIA2 confirmed that OR51E2 and OR51E1 were significantly overexpressed in prostate cancer tissues, with OR51E2 being the more deregulated of the two (Fig. 6a and Extended Data Fig. 8a). Here, OR51E2 is linked to prostate cancer.